Notice: This company has been marked as potentially delisted and may not be actively trading. Gamida Cell (GMDA) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock Analysis Gamida Cell Short Interest DataGamida Cell (GMDA) has a short interest of 10.96 million shares. This marks a 9.82% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.6, indicating that it would take 3.6 days of the average trading volume of 9.20 million shares to cover all short positions.Current Short Interest10,960,000 sharesPrevious Short Interest9,980,000 sharesChange Vs. Previous Month+9.82%Dollar Volume Sold Short$3.50 millionShort Interest Ratio3.6 Days to CoverLast Record DateMarch 15, 2024Outstanding Shares154,051,000 sharesPercentage of Shares Shorted7.11%Today's Trading Volume23,036,800 sharesAverage Trading Volume9,201,723 sharesToday's Volume Vs. Average250% Short Selling Gamida Cell? Sign up to receive the latest short interest report for Gamida Cell and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGMDA Short Interest Over TimeGMDA Days to Cover Over TimeGMDA Percentage of Float Shorted Over Time Remove Ads Gamida Cell Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/202410,960,000 shares $3.50 million +9.8%N/A3.6 $0.32 2/29/20249,980,000 shares $3.59 million +0.2%N/A3.4 $0.36 2/15/20249,960,000 shares $3.93 million +12.4%N/A3.1 $0.40 1/31/20248,860,000 shares $3.41 million +11.7%N/A2.4 $0.39 1/15/20247,930,000 shares $2.27 million +19.1%N/A2.7 $0.29 12/31/20236,660,000 shares $2.75 million -5.4%N/A2.7 $0.41 12/15/20237,040,000 shares $2.22 million -16.3%N/A3.5 $0.32 11/30/20238,410,000 shares $2.61 million +1.8%N/A4.5 $0.31 11/15/20238,260,000 shares $3.01 million +12.4%N/A5.1 $0.37 10/31/20237,350,000 shares $5.40 million +10.7%N/A7.1 $0.74 Get the Latest News and Ratings for GMDA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gamida Cell and its competitors with MarketBeat's FREE daily newsletter. 10/15/20236,640,000 shares $5.38 million +6.8%N/A5.8 $0.81 9/30/20236,220,000 shares $6.41 million +12.1%N/A4.9 $1.03 9/15/20235,550,000 shares $6.33 million +10.6%N/A3.8 $1.14 8/31/20235,020,000 shares $5.92 million +10.1%N/A3.2 $1.18 8/15/20234,560,000 shares $5.70 million +14.0%N/A2.5 $1.25 7/31/20234,000,000 shares $5.72 million +22.7%N/A1.8 $1.43 7/15/20233,260,000 shares $4.92 million -11.4%N/A1.1 $1.51 6/30/20233,680,000 shares $7.10 million -13.8%N/A0.7 $1.93 6/15/20234,270,000 shares $8.37 million +34.3%N/A0.8 $1.96 5/31/20233,180,000 shares $6.68 million -35.9%N/A0.6 $2.10 5/15/20234,960,000 shares $10.12 million -39.5%N/A1 $2.04 4/30/20238,200,000 shares $13.12 million +13.7%N/A1.9 $1.60 4/15/20237,210,000 shares $5.82 million +11.1%N/A1.9 $0.81 3/31/20236,490,000 shares $5.26 million +26.3%11.3%6 $0.81 3/15/20235,140,000 shares $7.86 million -7.7%9.8%8.4 $1.53 2/28/20235,570,000 shares $8.19 million -2.6%9.8%10.1 $1.47 2/15/20235,720,000 shares $8.12 million +8.8%10.1%11 $1.42 1/31/20235,260,000 shares $8.42 million +14.6%N/A10 $1.60 1/15/20234,590,000 shares $7.30 million +15.3%N/A8.8 $1.59 12/30/20223,980,000 shares $5.13 million -0.5%N/A7.8 $1.29 12/15/20224,000,000 shares $5.24 million -2.2%N/A7.2 $1.31 11/30/20224,090,000 shares $6.54 million +15.2%N/A7.9 $1.60 11/15/20223,550,000 shares $6.75 million +4.1%N/A6.7 $1.90 10/31/20223,410,000 shares $6.10 million +5.9%6.1%5.4 $1.79 10/15/20223,220,000 shares $5.57 million +40.0%5.8%4.8 $1.73 9/30/20222,300,000 shares $3.66 million -10.5%4.1%3.5 $1.59 9/15/20222,570,000 shares $6.63 million -5.2%5.7%4.5 $2.58 8/31/20222,710,000 shares $7.18 million -9.4%6.0%4.8 $2.65 8/15/20222,990,000 shares $9.66 million +15.4%6.6%5.6 $3.23 7/31/20222,590,000 shares $4.33 million -4.8%5.7%6.8 $1.67Your Wealth is Under Attack (Ad)Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.Get Your FREE Presidential Transition Guide Today 7/15/20222,720,000 shares $5.33 million +1.1%6.6%3.8 $1.96 6/30/20222,690,000 shares $4.76 million -4.3%6.5%3.7 $1.77 6/15/20222,810,000 shares $5.42 million -1.8%6.8%4 $1.93 5/31/20222,860,000 shares $6.23 million -5.9%6.9%4.1 $2.18 5/15/20223,040,000 shares $7.11 million -16.3%7.3%4.2 $2.34 4/30/20223,630,000 shares $9.26 million +37.5%8.8%4.8 $2.55 4/15/20222,640,000 shares $8.58 million +6.0%6.4%5.3 $3.25 3/31/20222,490,000 shares $10.33 million -6.7%6.0%3.2 $4.15 3/15/20222,670,000 shares $9.10 million +17.1%6.5%2.9 $3.41 2/28/20222,280,000 shares $7.66 million -15.9%5.6%2.4 $3.36 2/15/20222,710,000 shares $9.73 million +0.7%6.7%2.8 $3.59 1/31/20222,690,000 shares $8.96 million +63.0%6.6%2.7 $3.33 1/15/20221,650,000 shares $3.75 million +1.2%N/A1.8 $2.27 12/31/20211,630,000 shares $4.14 million +29.4%4.0%3 $2.54 12/15/20211,260,000 shares $3.05 million -8.7%3.1%3.1 $2.42 11/30/20211,380,000 shares $3.53 million -14.3%3.4%3.6 $2.56 11/15/20211,610,000 shares $5.47 million -1.8%3.9%4.1 $3.40 10/29/20211,640,000 shares $6.54 million +6.5%4.0%3.5 $3.99 10/15/20211,540,000 shares $6.16 million -3.1%3.7%2.8 $4.00 9/30/20211,590,000 shares $6.23 million -18.9%3.9%2.9 $3.92 9/15/20211,960,000 shares $7.78 million +23.3%4.8%3.7 $3.97 8/31/20211,590,000 shares $7.22 million -4.8%3.9%3.1 $4.54 8/13/20211,670,000 shares $9.13 million +6.4%4.1%3.6 $5.47 7/30/20211,570,000 shares $8.10 million -1.3%3.8%4.5 $5.16 7/15/20211,590,000 shares $9.14 million +8.9%3.9%6.2 $5.75 6/30/20211,460,000 shares $9.36 million -9.9%3.6%5.3 $6.41 6/15/20211,620,000 shares $10.42 million -12.0%4.0%5.5 $6.43 5/28/20211,840,000 shares $11.94 million +23.5%4.5%5.6 $6.49 5/14/20211,490,000 shares $9.39 million -28.7%N/A3.8 $6.30 4/30/20212,090,000 shares $15.59 million +36.6%N/A2.7 $7.46 4/15/20211,530,000 shares $12.38 million -7.8%N/A1.7 $8.09 3/31/20211,660,000 shares $13.03 million -15.7%N/A1.7 $7.85 3/15/20211,970,000 shares $17.65 million +72.8%N/A1.9 $8.96 2/26/20211,140,000 shares $10.84 million -14.3%N/A0.9 $9.51 2/12/20211,330,000 shares $14.83 million +83.5%N/A1.1 $11.15 1/29/2021724,800 shares $5.68 million +32.1%N/A0.9 $7.83 1/15/2021548,500 shares $5.13 million -4.0%N/A0.8 $9.36 12/31/2020571,500 shares $4.78 million -9.1%N/A0.9 $8.37 12/15/2020628,800 shares $5.72 million +32.6%2.3%1.1 $9.09 11/30/2020474,100 shares $3.15 million -0.9%1.7%1 $6.65 11/15/2020478,400 shares $2.87 million +43.7%1.8%1.8 $6.00 10/30/2020333,000 shares $1.78 million +68.1%1.2%1.3 $5.36 10/15/2020198,100 shares $1.03 million No Change0.7%0.8 $5.20 9/30/2020198,100 shares $822,115.00 -18.2%0.7%0.9 $4.15 9/15/2020242,100 shares $1.04 million -18.3%0.9%1.3 $4.29 8/31/2020296,200 shares $1.29 million +43.9%1.1%1.5 $4.36 8/14/2020205,900 shares $829,777.00 +20.0%0.8%0.8 $4.03 7/31/2020171,600 shares $688,116.00 +219.0%0.7%0.4 $4.01 7/15/202053,800 shares $232,416.00 +198.9%0.2%0.1 $4.32 6/30/202018,000 shares $82,260.00 -73.7%0.1%0.1 $4.57Your Wealth is Under Attack (Ad)Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your free gift, and see how Trump's victory could spark major gains for gold.Click here now to see how to stop them in their tracks! 6/15/202068,500 shares $332,225.00 +63.5%0.3%0.2 $4.85 5/29/202041,900 shares $235,897.00 +4.5%0.3%0.1 $5.63 5/15/202040,100 shares $254,234.00 +21.9%0.3%0.2 $6.34 4/30/202032,900 shares $140,812.00 +5.8%0.3%1.2 $4.28 4/15/202031,100 shares $116,936.00 +163.6%0.3%1.5 $3.76 3/31/202011,800 shares $48,970.00 +53.3%0.1%0.5 $4.15 3/13/20207,700 shares $25,949.00 +196.2%0.1%0.3 $3.37 GMDA Short Interest - Frequently Asked Questions What is Gamida Cell's current short interest? Short interest is the volume of Gamida Cell shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 10,960,000 shares of GMDA short. Learn More on Gamida Cell's current short interest. What is a good short interest ratio for Gamida Cell? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GMDA shares currently have a short interest ratio of 4.0. Learn More on Gamida Cell's short interest ratio. Is Gamida Cell's short interest increasing or decreasing? Gamida Cell saw a increase in short interest in March. As of March 15th, there was short interest totaling 10,960,000 shares, an increase of 9.8% from the previous total of 9,980,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Gamida Cell's short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Gamida Cell: IN8bio, Inc. (1.24%), Cognition Therapeutics, Inc. (6.27%), BioAtla, Inc. (7.43%), Athira Pharma, Inc. (2.48%), SAB Biotherapeutics, Inc. (1.68%), Senti Biosciences, Inc. (2.23%), Organovo Holdings, Inc. (9.33%), PharmaCyte Biotech, Inc. (0.24%), BioCardia, Inc. (0.65%), Avalon GloboCare Corp. (10.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Gamida Cell stock? Short selling GMDA is an investing strategy that aims to generate trading profit from Gamida Cell as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gamida Cell? A short squeeze for Gamida Cell occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GMDA, which in turn drives the price of the stock up even further. How often is Gamida Cell's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GMDA, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies IN8bio Short Interest Cognition Therapeutics Short Interest BioAtla Short Interest Athira Pharma Short Interest SAB Biotherapeutics Short Interest Senti Biosciences Short Interest Organovo Short Interest PharmaCyte Biotech Short Interest BioCardia Short Interest Avalon GloboCare Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GMDA) was last updated on 3/13/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gamida Cell Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gamida Cell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
